Earnings Outlook For CollPlant Biotechnologies
Portfolio Pulse from Benzinga Insights
CollPlant Biotechnologies (NASDAQ:CLGN) is expected to release its quarterly earnings report on Wednesday, 2023-11-29, with analysts predicting an EPS of $-0.13. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, the company's stock price has been sensitive to earnings performance and guidance. Last quarter, CLGN beat the EPS estimate by $0.51, resulting in a 5.23% stock price increase the following day. Over the last 52 weeks, CLGN shares have risen by 22.65%, indicating a bullish sentiment among long-term shareholders.
November 28, 2023 | 6:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CollPlant Biotechnologies is anticipated to release its quarterly earnings with an expected EPS of $-0.13. Positive earnings performance and guidance could influence the stock price, as seen in the past. Long-term shareholders are bullish, with a 22.65% increase in stock value over the past year.
Given the historical data showing that CLGN's stock price has been positively impacted by earnings beats and the company's stock has been on an upward trend over the past year, there is a reasonable expectation that a positive earnings report and guidance could lead to a short-term increase in stock price. However, the market's reaction can be unpredictable, and other factors not mentioned in the article could also affect the stock's performance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100